SCHEMBL26993127

SCHEMBL26993127

C#CCOCCOCCOCCOCCOc1ccc(N2CCN(C(=O)OC(C)(C)C)CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.50
▸ LMNA P02545 2/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ GPR119 Q8TDV5 8/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ KIT P10721 1/20 0.46
▸ FLT3 P36888 1/20 0.46
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ MAOB P27338 1/20 0.44
▸ NAMPT P43490 1/20 0.44
▸ DDB1 Q16531 1/20 0.44
▸ CRBN Q96SW2 1/20 0.44
▸ ESRRB O95718 1/20 0.43
▸ ESR1 P03372 1/20 0.43
▸ ESRRA P11474 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17275263 0.89 GPR119 (0.56) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL21659296 0.87 MAPT (0.57) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL31715968 0.86 MAPT (0.53) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL21659187 0.83 MAPT (0.60) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL23868398 0.82 MAPT (0.58) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL21659378 0.82 MAPT (0.58) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL22776398 0.82 MAPT (0.58) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL21659380 0.81 MAPT (0.55) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL22638159 0.81 KIT (0.65) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL21659329 0.81 MAPT (0.57) MAPTLMNAALDH1A1GPR119SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024010810-A2 FC CONJUGATES INCLUDING AN INHIBITOR OF CD73 AND USES THEREOF CIDARA THERAPEUTICS, INC. (US) 2024-01-11 — — WO disclosed
Send feedback